In Unruptured Brain Arteriovenous Malformations, Conservative Management Outshines Interventional Treatment

Publication
Article
Internal Medicine World ReportMay 2014

Among patients aged 16 years or older with unruptured brain arteriovenous malformations (AVMs), conservative management produces better clinical outcomes than any endovascular embolization, neurosurgical excision, or stereotactic radiosurgery.

Among patients aged 16 years or older with unruptured brain arteriovenous malformations (AVMs), conservative management produces better clinical outcomes than any endovascular embolization, neurosurgical excision, or stereotactic radiosurgery, according to research published in the April 23/30, 2014, issue of the Journal of the American Medical Association.

For their study, Rustam Al-Shahi Salman, PhD, of the Centre for Clinical Brain Sciences at the University of Edinburgh, and colleagues prospectively followed 204 brain AVM patients in Scotland — 103 of whom underwent an intervention — for 12 years. The researchers performed Cox regression analyses with multivariable adjustment for prognostic health factors and baseline imbalances to compare the rates of death or sustained morbidity of any cause, as well as nonfatal symptomatic stroke or death due to brain AVM, associated arterial aneurysm, or intervention.

According to the study authors, the unruptured brain AVM patients who underwent an endovascular embolization, neurosurgical excision, or stereotactic radiosurgery alone or in combination were “younger, more likely to have presented with seizure, and less likely to have large brain AVMs than patients managed conservatively” with no intervention. During a median follow-up period of 6.9 years, the rate of progression to the aforementioned primary study outcomes was lower with conservative management during the first 4 years of follow-up, although the rates were similar thereafter. The rate of nonfatal symptomatic stroke or death due to brain AVM, associated arterial aneurysm, or intervention was also lower with conservative management during 12 years of follow-up.

In light of that evidence, the researchers concluded “use of conservative management compared with intervention was associated with better clinical outcomes for up to 12 years” among patients aged 16 years or older diagnosed as having unruptured brain AVM. However, they noted a longer follow-up period is needed to ensure the association persists long-term.

Related Videos
Getting Black Men Involved in Their Health Care, Clinical Research
Patient Involvement in Advanced HF Treatment, with Ashley Malliett, DMSc, MPAS, PA-C
Aaron Henry, PA-C, MSHS: Regaining Black Male Patient Trust in the Doctor's Office
How to Adequately Screen for and Treat Cognitive Decline in Primary Care
Tailoring Chest Pain Diagnostics to Patients, with Kyle Fortman, PA-C, MBA
James R. Kilgore, DMSc, PhD, PA-C: Cognitive Decline Diagnostics
Solutions to Prevent Climate Change-Related Illness, with Janelle Bludhorn, PA-C
Kyle Fortman, PA-C, MBA: Troponin and Heart Injury Risk Screening Recommendations
What Should the American Academy of Physician Associates Focus on in 2025?
The Rising Rate of Heat-Related Illness, with Janelle Bludhorn, PA-C
© 2024 MJH Life Sciences

All rights reserved.